<DOC>
	<DOCNO>NCT02471807</DOCNO>
	<brief_summary>The study multi-center , prospective , early feasibility study measure individual patient clinical outcome effectiveness , evaluate safety function , provide guidance future clinical study design development effort Edwards FORMA Tricuspid Transcatheter Repair System .</brief_summary>
	<brief_title>Early Feasibility Study Edwards FORMA Tricuspid Transcatheter Repair System</brief_title>
	<detailed_description>The early feasibility study Edwards FORMA Tricuspid Transcatheter Repair System multi-center , prospective , early feasibility study measure individual patient clinical outcome effectiveness , evaluate safety function , provide guidance future clinical study design development effort Edwards FORMA Tricuspid Transcatheter Repair System . Data collect clinical study include safety function investigational system well 3 year clinical outcome .</detailed_description>
	<mesh_term>Tricuspid Valve Insufficiency</mesh_term>
	<criteria>1 . Clinically significant , symptomatic ( NYHA Functional Class II great ) functional secondary , tricuspid regurgitation ( per applicable guideline ) require tricuspid valve repair replacement assess Heart Team 2 . NYHA Functional Class II great sign persistent right heart failure despite optimal medical therapy 3 . Determined 'HEART Team ' ( minimum one Cardiologist , one Cardiac Surgeon ) high surgical risk tricuspid valve repair replacement benefitrisk analysis support utilization investigational device See Protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>